Sirona Medical Raises $40M Series D for Cloud Radiology and AI
Avidity Partners leads Sirona Medical’s $40M Series D. The radiology platform’s contracted exam volumes and growth claims need careful interpretation.
Healthtech venture capital spans digital health platforms, care delivery innovation, diagnostics, and AI-enabled clinical workflows. Our healthtech coverage tracks the funding rounds and fund strategies defining the next generation of healthcare technology.
Browse healthtech venture capital articles below.
Avidity Partners leads Sirona Medical’s $40M Series D. The radiology platform’s contracted exam volumes and growth claims need careful interpretation.
Sava Technologies raised a $36 million Series B led by Ascensia Diabetes Care and paired it with a European distribution agreement for its glucose microsensor.
Inspiren raised $70M on Sep 10, 2026 — NewView led at >$500M valuation; $225M total — with Insight and Scale Venture Partners returning as senior-living operators push ambient AI and e-call upgrades.
Insight led $13.3M Series A for Graph Safety on Sep 10, 2026, with Bessemer returning — company claims live PV deployments cut case turnaround >90% and opex up to 66% for pharma safety teams.
Tandem Health closed a $100M Series B led by EQT’s Scaleup Europe Fund on September 14, 2026 — the fund’s first healthcare check — at 10,000 care organisations across 14 markets and $160M total funding. Valuation was not disclosed.
Thatch raised $108 million Series C at a $1 billion valuation on September 15, 2026 from Index, a16z, General Catalyst, Scale, and The General Partnership. Company: ARR nearly 7× YoY; 5,000+ employers. Prior Series B was $40M at $410M.
Evvy raised a $40 million Series B led by Catalio Capital Management on September 15, 2026. Company: 100,000+ patients, 3,000 practitioners, CLIA/CLEP mNGS vaginal microbiome tests. Valuation not disclosed.
Day index for September 18–19, 2026: Angle Health’s $200M Series C at $2.7B, D-Robotics $400M Series C, Vantora >$100M, Mantic $25M — plus Polyphron, Veridion, and Manus talks briefs.
Vitruvian led Angle Health’s $200M Series C (YC W20) at $2.7B with a $400M tender. Who buys level-funded SMB plans, why profitability matters, and why a European growth firm fits.
San Diego venture map in 2026 — Shield AI, SkySafe, ClickUp, Turquoise Health, Function Oncology, Comma, national investor links, and honest Torrey Pines biotech gaps.
Greater Phoenix venture map in 2026 — Copper Sky Capital, PHX Ventures, Arizona Founders Fund, PHX Angels, plus Basata, Nx, Nuclearn, One Raven, and Synthreo.
Oklahoma City venture map in 2026 — Paycom (NYSE: PAYC), Apricot's Insight-led Series A, Tobe Energy and Galvanic Energy, plus Cortado Ventures, Plains Ventures, and i2E.